SARIN ARADHANA 4
4 · ALEXION PHARMACEUTICALS, INC. · Filed Jul 16, 2021
Insider Transaction Report
Form 4
SARIN ARADHANA
EVP, CFO
Transactions
- Award
Common Stock, par value $.0001 per share
[F1]2021-07-14+26,812→ 90,752 total - Award
Common Stock, par value $.0001 per share
[F2]2021-07-14+29,501→ 120,253 total
Footnotes (2)
- [F1]On July 14, 2021 the Leadership and Compensation Committee certified that certain performance metrics under previously granted performance stock units were satisfied. These performance stock units were previously granted in February 2019 under the 2017 Stock Incentive Plan.
- [F2]On July 14, 2021 the Leadership and Compensation Committee certified that certain performance metrics under previously granted performance stock units were satisfied. These performance stock units were previously granted in February 2020 under the 2017 Stock Incentive Plan.
Signature
/s/ Douglas Barry, Attorney-in-Fact for Aradhana Sarin|2021-07-16